Elbasvir-grazoprevir works effectively against HCV despite current drug use

A 12-week course of elbasvir plus grazoprevir proved effective against hepatitis C virus in 301 patients who were receiving opioid agonist therapy for injectable drug addiction, according to a report...
Source: Family Practice News - Category: Primary Care Source Type: news